Page 3 - Onxeo Stock Exchange News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Onxeo stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Onxeo Stock Exchange Today - Breaking & Trending Today

Onxeo S.A.: ONXEO Provides Update on the Development Program For Its First-in-class Drug Candidate AsiDNATM

Phase 1b/2 trial of AsiDNATM in combination with olaparib initiated in the United States in recurrent ovarian, breast and metastatic castration-resistant prostate cancer Phase 1b/2 trial (REVOCAN) ....

United States , San Antonio , France General , Shefali Agarwal , Arthur Rouill , Nicolas Fossiez , Onxeo Sa Euronext , Institut Curie , Company Group , Euronext Growth Paris , Next Oncology San , Gustave Roussy Cancer Campus , Grand Paris , Euronext Paris ,

Onxeo S.A.: Onxeo: Extraordinary General Meeting of February 6, 2023: Availability of Preparatory Documents

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), hereafter "Onxeo" or the "Company", a clinical stage biotechnology company specializing in the development of innovative drugs targeting ....

France General , Arthur Rouill , Onis Onxeo , Raymond Poincar , Onxeo Sa Euronext , Emmanuel Huynh , Renaissance Paris Nobel Tour Eiffel Hotel , Company Group , Regulatory News , Euronext Growth Paris , Extraordinary General Meeting , General Meeting , General Meetings ,

Onxeo: Extraordinary General Meeting of February 6, 2023: Availability of Preparatory Documents

18.01.2023 - Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), hereafter Onxeo or the Company , a clinical stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA damage response (DDR) mechanisms to fight . ....

Company Group , General Meeting , General Meetings , Euronext Growth Paris , Onxeo Stock ,

Half-year liquidity contract statement for ONXEO

Regulatory News: Under the liquidity contract entered into between ONXEO (Paris:ALONX) (NASDAQ OMX:ONXEO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on December ....

France General , Kepler Cheuvreux , Regulatory News ,

Onxeo Advances Its Second Lead Candidate OX425 for the Treatment of Solid Tumors

OX425 is a novel DDR Decoy Agonist which also mediates multiple immunostimulatory effects, making it a promising candidate for combination with immunotherapy, especially in "cold" tumors Late-stage ....

France General , Shefali Agarwal , Arthur Rouill , Onis Onxeo , Onxeo Sa Euronext , Emmanuel Huynh , Company Group , Euronext Growth Paris , Investigational New Drug ,